Literature DB >> 24461382

Criteria for Behçet's disease with reflections on all disease criteria.

Hasan Yazici1, Yusuf Yazici2.   

Abstract

With no specific histologic, laboratory or imaging features the diagnosis/classification of Behçet's Disease (BD) remains clinical. As such, disease criteria are needed. The International Study Group Criteria set is the most widely used. It has some limitations, especially in telling BD from Crohn's disease. On the other hand the main issue, as it also applies to many of the other criteria sets in rheumatology, is our lack of appreciation of a list of misconceptions--some examples of which are unluckily also found in the 2010 ACR/EULAR RA Criteria set--about diagnostic/classification criteria making and their implementation. 1. The view that classification and diagnostic criteria should be different is ill advised in that the cerebral/arithmetic basis of both are the same. 2. The default promise of diagnostic criteria to come once we formulate a classification criteria set is an extension of the previous misconception. 3.Taking pains to avoid circularity in criteria making is unwarranted since the essence of criteria making is circular. In addition we fail to exploit the utility of the disease criteria in ruling out, rather than ruling in, the diseases we seek. Finally we also fail to appreciate the paramount importance of the Bayesian prior (the pretest) probability in formulating and implementing these disease criteria. To formulate criteria tailored to subspecialties, as well as giving the often forgotten family history more importance in our criteria sets are some ways to improve the prior probability on which our diagnostic/classification decisions will be based. We first have to reconcile with ourselves that probabilities are very important in our practice and research. Moreover that reconciliation must also be shared with the public, which includes our patients.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bayes theorem; Behçet's disease; Circularity; Classification criteria; Diagnostic criteria; RA criteria

Mesh:

Year:  2014        PMID: 24461382     DOI: 10.1016/j.jaut.2014.01.014

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  14 in total

Review 1.  Behcet colitis.

Authors:  Anne B Chin; Anjali S Kumar
Journal:  Clin Colon Rectal Surg       Date:  2015-06

Review 2.  Critical appraisal of classification criteria for vasculitides.

Authors:  Luis Felipe Flores-Suárez; Felipe de J Contreras-Rodríguez
Journal:  Curr Rheumatol Rep       Date:  2014-06       Impact factor: 4.592

Review 3.  The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review.

Authors:  Angela Ceribelli; Maria De Santis; Natasa Isailovic; M Eric Gershwin; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 4.  Behçet syndrome: from pathogenesis to novel therapies.

Authors:  Gianluigi Mazzoccoli; Angela Matarangolo; Rosa Rubino; Michele Inglese; Angelo De Cata
Journal:  Clin Exp Med       Date:  2014-12-02       Impact factor: 3.984

Review 5.  Behçet Disease: An Update for Dermatologists.

Authors:  Erkan Alpsoy; Burcin Cansu Bozca; Asli Bilgic
Journal:  Am J Clin Dermatol       Date:  2021-06-01       Impact factor: 7.403

Review 6.  Autoimmunity in 2014.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

Review 7.  Unmet Needs in the Pathogenesis and Treatment of Vasculitides.

Authors:  Francesco Muratore; Giulia Pazzola; Alessandra Soriano; Nicolò Pipitone; Stefania Croci; Martina Bonacini; Luigi Boiardi; Carlo Salvarani
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

Review 8.  Ocular Involvement in Systemic Autoimmune Diseases.

Authors:  Elena Generali; Luca Cantarini; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

9.  Gene Expression Profiling in Behcet's Disease Indicates an Autoimmune Component in the Pathogenesis of the Disease and Opens New Avenues for Targeted Therapy.

Authors:  Antonio Puccetti; Piera Filomena Fiore; Andrea Pelosi; Elisa Tinazzi; Giuseppe Patuzzo; Giuseppe Argentino; Francesca Moretta; Claudio Lunardi; Marzia Dolcino
Journal:  J Immunol Res       Date:  2018-04-24       Impact factor: 4.818

Review 10.  Behçet's syndrome: providing integrated care.

Authors:  Sinem Nihal Esatoglu; Zekayi Kutlubay; Didar Ucar; Ibrahim Hatemi; Ugur Uygunoglu; Aksel Siva; Gulen Hatemi
Journal:  J Multidiscip Healthc       Date:  2017-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.